drugset / Trial / NCT02721940

Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

NCT02721940

Unknown 100 enrolled Chinese PLA General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This study was mainly aimed to evaluate the efficacy of local administration of enriched bone marrow mononuclear cells, platelets and zoledronic acid for the clinical prevention of collapse of the early-stage osteonecrotic femoral head.

Timeline

Start
2012-02
Primary completion
2015-01
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mononuclear cells Cell therapy Other
Subject Platelets Other / unclassified Other
Subject Zoledronic acid Other / unclassified 200 ug Other

Indications